InvestorsHub Logo

ggwpq

05/26/17 8:28 AM

#106931 RE: AVII77 #106929

AVII, thanks for your reply. Given V's safety profile compared with other lipid agents in the market, if Amarin is a "person", it has a serious case of discrimination Vs. the FDA.